(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TIMELESS mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:731568 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TIMELESS mRNA CTD PMID:36331819 17alpha-ethynylestradiol multiple interactions ISO RGD:731568 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TIMELESS mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:731568 6480464 Ethinyl Estradiol results in increased expression of TIMELESS mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:731567 6480464 Estradiol results in increased expression of TIMELESS mRNA CTD PMID:15223131 , PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:731568 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:731568 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731568 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TIMELESS mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TIMELESS promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731568 6480464 Tetrachlorodibenzodioxin affects the expression of TIMELESS mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of TIMELESS mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:731568 6480464 Fenretinide results in increased expression of TIMELESS mRNA CTD PMID:28973697 5-fluorouracil affects response to substance ISO RGD:731567 6480464 TIMELESS protein affects the susceptibility to Fluorouracil CTD PMID:15548681 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TIMELESS mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of TIMELESS mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:731567 6480464 Acrylamide results in decreased expression of TIMELESS mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:731568 6480464 Aflatoxin B1 results in decreased expression of TIMELESS mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:731567 6480464 Tretinoin results in decreased expression of TIMELESS mRNA CTD PMID:33167477 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of TIMELESS mRNA CTD PMID:30779732 arsenite(3-) multiple interactions ISO RGD:731567 6480464 arsenite inhibits the reaction [G3BP1 protein binds to TIMELESS mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:731567 6480464 Arsenic Trioxide results in decreased expression of TIMELESS mRNA CTD PMID:20458559 benzo[a]pyrene decreases expression ISO RGD:731568 6480464 Benzo(a)pyrene results in decreased expression of TIMELESS mRNA CTD PMID:19770486 , PMID:21569818 benzo[a]pyrene affects methylation ISO RGD:731567 6480464 Benzo(a)pyrene affects the methylation of TIMELESS promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:731568 6480464 Benzo(a)pyrene results in increased expression of TIMELESS mRNA CTD PMID:20713471 , PMID:22228805 benzo[b]fluoranthene increases expression ISO RGD:731568 6480464 benzo(b)fluoranthene results in increased expression of TIMELESS mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731567 6480464 Diethylhexyl Phthalate results in increased expression of TIMELESS protein CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TIMELESS mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TIMELESS mRNA CTD PMID:30816183 bisphenol A decreases methylation ISO RGD:731568 6480464 bisphenol A results in decreased methylation of TIMELESS promoter CTD PMID:27312807 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of TIMELESS mRNA CTD PMID:32479839 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of TIMELESS promoter CTD PMID:22457795 caffeine affects phosphorylation ISO RGD:731567 6480464 Caffeine affects the phosphorylation of TIMELESS protein CTD PMID:35688186 carbon nanotube increases expression ISO RGD:731568 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of TIMELESS mRNA CTD PMID:18500788 choline multiple interactions ISO RGD:731568 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TIMELESS gene CTD PMID:20938992 cisplatin increases expression ISO RGD:731567 6480464 Cisplatin results in increased expression of TIMELESS mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:731567 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of TIMELESS mRNA CTD PMID:27392435 copper(II) sulfate decreases expression ISO RGD:731567 6480464 Copper Sulfate results in decreased expression of TIMELESS mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:731567 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol increases expression ISO RGD:731567 6480464 Coumestrol results in increased expression of TIMELESS mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:731568 6480464 Asbestos, Crocidolite results in increased expression of TIMELESS mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:731567 6480464 Cyclosporine results in decreased expression of TIMELESS mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:731567 6480464 Cyclosporine results in increased expression of TIMELESS mRNA CTD PMID:25562108 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of TIMELESS mRNA CTD PMID:23640034 diarsenic trioxide decreases expression ISO RGD:731567 6480464 Arsenic Trioxide results in decreased expression of TIMELESS mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:731568 6480464 Dibutyl Phthalate results in decreased expression of TIMELESS mRNA CTD PMID:17361019 , PMID:21266533 dioxygen decreases expression ISO RGD:731567 6480464 Oxygen deficiency results in decreased expression of TIMELESS mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:731567 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Enterolactone multiple interactions ISO RGD:731567 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TIMELESS mRNA CTD PMID:19167446 epoxiconazole decreases expression ISO RGD:731568 6480464 epoxiconazole results in decreased expression of TIMELESS mRNA CTD PMID:35436446 folic acid multiple interactions ISO RGD:731568 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TIMELESS gene CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:731567 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of TIMELESS mRNA CTD PMID:19016759 fulvestrant decreases expression ISO RGD:731567 6480464 fulvestrant results in decreased expression of TIMELESS mRNA CTD PMID:19016759 furan increases expression EXP 6480464 furan results in increased expression of TIMELESS mRNA CTD PMID:25539665 geraniol decreases expression ISO RGD:731567 6480464 geraniol results in decreased expression of TIMELESS mRNA CTD PMID:27683099 L-methionine multiple interactions ISO RGD:731568 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TIMELESS gene CTD PMID:20938992 menadione affects expression ISO RGD:731567 6480464 Vitamin K 3 affects the expression of TIMELESS mRNA CTD PMID:20044591 microcystin-LR decreases expression ISO RGD:731567 6480464 cyanoginosin LR results in decreased expression of TIMELESS protein CTD PMID:36435412 microcystin-LR multiple interactions ISO RGD:731567 6480464 [cyanoginosin LR inhibits the reaction [PARP1 protein binds to TIMELESS protein]] promotes the reaction [CGAS protein binds to PARP1 protein] more ... CTD PMID:36435412 Monobutylphthalate affects expression EXP 6480464 monobutyl phthalate affects the expression of TIMELESS mRNA CTD PMID:20864626 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TIMELESS mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:731568 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TIMELESS mRNA CTD PMID:34911549 paracetamol affects expression ISO RGD:731568 6480464 Acetaminophen affects the expression of TIMELESS mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:731567 6480464 Acetaminophen results in increased expression of TIMELESS mRNA CTD PMID:22230336 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of TIMELESS mRNA CTD PMID:32680482 PCB138 multiple interactions ISO RGD:731568 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid decreases expression ISO RGD:731567 6480464 perfluoro-n-nonanoic acid results in decreased expression of TIMELESS mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731568 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of TIMELESS mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of TIMELESS mRNA CTD PMID:36331819 phenethyl isothiocyanate decreases expression ISO RGD:731567 6480464 phenethyl isothiocyanate results in decreased expression of TIMELESS mRNA CTD PMID:26678675 phenobarbital affects expression ISO RGD:731567 6480464 Phenobarbital affects the expression of TIMELESS mRNA CTD PMID:19159669 phenobarbital affects expression ISO RGD:731568 6480464 Phenobarbital affects the expression of TIMELESS mRNA CTD PMID:19136022 , PMID:23091169 phenylmercury acetate decreases expression ISO RGD:731567 6480464 Phenylmercuric Acetate results in decreased expression of TIMELESS mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731567 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIMELESS mRNA CTD PMID:27188386 pirinixic acid affects expression ISO RGD:731568 6480464 pirinixic acid affects the expression of TIMELESS mRNA CTD PMID:19136022 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of TIMELESS mRNA CTD PMID:12832660 , PMID:19162173 pirinixic acid multiple interactions ISO RGD:731568 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of TIMELESS mRNA] CTD PMID:17950772 pirinixic acid increases expression ISO RGD:731568 6480464 pirinixic acid results in increased expression of TIMELESS mRNA CTD PMID:17950772 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of TIMELESS mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:731568 6480464 Pregnenolone Carbonitrile results in increased expression of TIMELESS mRNA CTD PMID:22698814 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of TIMELESS mRNA CTD PMID:20726854 quercetin increases expression ISO RGD:731567 6480464 Quercetin results in increased expression of TIMELESS mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:731567 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of TIMELESS mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of TIMELESS mRNA CTD PMID:19167446 , PMID:23557933 resveratrol increases expression ISO RGD:731567 6480464 resveratrol results in increased expression of TIMELESS mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:731567 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sirolimus multiple interactions ISO RGD:731567 6480464 [fulvestrant co-treated with Sirolimus] results in decreased expression of TIMELESS mRNA CTD PMID:19016759 sodium arsenite increases expression ISO RGD:731567 6480464 sodium arsenite results in increased expression of TIMELESS mRNA CTD PMID:34032870 sodium dichromate decreases expression ISO RGD:731568 6480464 sodium bichromate results in decreased expression of TIMELESS mRNA CTD PMID:31558096 Soman increases expression EXP 6480464 Soman results in increased expression of TIMELESS mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:731567 6480464 Sunitinib results in decreased expression of TIMELESS mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:731567 6480464 Temozolomide results in increased expression of TIMELESS mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO RGD:731568 6480464 Carbon Tetrachloride affects the expression of TIMELESS mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:731568 6480464 Carbon Tetrachloride results in increased expression of TIMELESS mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of TIMELESS mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TIMELESS mRNA] CTD PMID:31150632 thapsigargin decreases expression ISO RGD:731567 6480464 Thapsigargin results in decreased expression of TIMELESS mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of TIMELESS mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:731568 6480464 titanium dioxide results in increased expression of TIMELESS mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of TIMELESS mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TIMELESS mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of TIMELESS mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:731568 6480464 trimellitic anhydride results in increased expression of TIMELESS mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of TIMELESS mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:731568 6480464 triptonide results in increased expression of TIMELESS mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:731567 6480464 troglitazone results in decreased expression of TIMELESS mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO RGD:731568 6480464 trovafloxacin results in decreased expression of TIMELESS mRNA CTD PMID:35537566 tungsten decreases expression ISO RGD:731568 6480464 Tungsten results in decreased expression of TIMELESS mRNA CTD PMID:30912803 urethane decreases expression ISO RGD:731567 6480464 Urethane results in decreased expression of TIMELESS mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:731567 6480464 Valproic Acid affects the expression of TIMELESS mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:731567 6480464 Valproic Acid results in decreased expression of TIMELESS mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:731567 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TIMELESS mRNA CTD PMID:27188386